Hong Kong Pharma Digital Technology plans 2025 AGM, equity plan

Rhea-AI Filing Summary

Hong Kong Pharma Digital Technology Holdings Limited (HKPD) reported that it will hold its annual general meeting of shareholders on December 12, 2025 at 10:00 a.m. Hong Kong Time (December 11, 2025 at 9:00 p.m. Eastern Time). The meeting will take place at the company’s principal office in Yau Tong, Kowloon, Hong Kong.

The company is providing shareholders with a proxy statement and notice of meeting, a form of proxy card, a proposed 2025 Equity Incentive Plan, and a form of fourth amended and restated memorandum and articles of association, all of which are furnished as exhibits and incorporated by reference.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

_______________

FORM 6-K

_______________

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2025

Commission File Number 001-42468

_______________

Hong Kong Pharma Digital Technology Holdings Limited (Registrant’s Name)

_______________

Room B1, 5/F., Well Town Industrial Building,
13 Ko Fai Road, Yau Tong, Kowloon
Hong Kong
(Address of principal executive office)

_______________

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☒            Form 40-F ☐

Annual General Meeting of Shareholders

On November 24, 2025, Hong Kong Pharma Digital Technology Holdings Limited (the “Company”) announced that it will hold an annual general meeting of shareholders (the “Meeting”) on December 12, 2025 at 10:00 a.m., Hong Kong Time (December 11, 2025, at 9:00 p.m., Eastern Time). The Meeting will be held at Room B1, 5/F., Well Town Industrial Building, 13 Ko Fai Road, Yau Tong, Kowloon, Hong Kong.

In connection with the annual general meeting of shareholders of the Company, the Company hereby furnishes the following documents which are incorporated by reference herein:

Exhibits

Exhibit No.		Description
99.1		Proxy Statement and Notice of Annual General Meeting of Shareholders, dated November 24, 2025
99.2		Form of Proxy Card of Annual General Meeting of Shareholders
99.3		Hong Kong Pharma Digital Technology Holdings Limited 2025 Equity Incentive Plan
99.4		Form of fourth amended and restated memorandum and articles of association

1

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		Hong Kong Pharma Digital Technology Holdings Limited
		By:		/s/ Chenyu Liang
		Name:		Chenyu Liang
		Title:		Director and Chief Executive Officer

Date: November 24, 2025

2

FAQ

When is HKPD's 2025 annual general meeting of shareholders?

The annual general meeting of shareholders of Hong Kong Pharma Digital Technology Holdings Limited is scheduled for December 12, 2025 at 10:00 a.m. Hong Kong Time (December 11, 2025 at 9:00 p.m. Eastern Time).

Where will HKPD hold its 2025 annual general meeting?

The meeting will be held at Room B1, 5/F., Well Town Industrial Building, 13 Ko Fai Road, Yau Tong, Kowloon, Hong Kong, which is the company’s principal executive office.

What key documents did HKPD furnish with the Form 6-K for the annual meeting?

Hong Kong Pharma Digital Technology Holdings Limited furnished a proxy statement and notice of annual general meeting, a form of proxy card, the 2025 Equity Incentive Plan, and a form of fourth amended and restated memorandum and articles of association as exhibits.

What is the purpose of HKPD's 2025 Equity Incentive Plan mentioned in the exhibits?

The filing identifies a Hong Kong Pharma Digital Technology Holdings Limited 2025 Equity Incentive Plan as an exhibit to be considered in connection with the annual general meeting; detailed terms are contained in the exhibit itself.

What corporate governance document is HKPD proposing to amend or restate?

The company included as an exhibit a form of fourth amended and restated memorandum and articles of association, indicating proposed updated governing documents tied to the annual general meeting.

Who signed the HKPD Form 6-K related to the 2025 annual meeting?

The report was signed on behalf of Hong Kong Pharma Digital Technology Holdings Limited by Chenyu Liang, who is identified as Director and Chief Executive Officer.